Forms Processing
PRODUCTS
-
Become compliant with FDA 21 CFR Part 11 and EudraLex Annex 11 software validation
SoftMax® Pro 7.2 GxP Software is the latest, most secure software to achieve full FDA 21 CFR Part 11 and EudraLex Annex 11 compliance with streamlined workflows to ensure data integrity. Every step is optimized to simplify analysis and reporting to support our microplate readers.
-
Patients shouldn’t have to jump through hoops. Discover an innovative portal that lets them handle travel and reimbursement directly—securely, simply, and without extra calls to the site.
-
Enhance your workflow with the Avanti JXN-26 high-speed Centrifuge System
- 6.0 L Max Capacity
- 26,000 RPM
- 81,770 x g
-
Precise, Complete, and Ultimate Detection.
A premium dual energy x-ray inspection system offering outstanding detection of hard-to-find, low density contaminants, in a variety of applications. Available in standard and custom configurations
Detect Hard-to-Find Contaminants
Capable of detecting hard-to-find contaminants in a variety of applications. Offering clarity and precision in complex areas of product inspection.
Enhance Product Quality
Achieves outstanding product quality using advanced levels of foreign body detection of low-density contaminants in overlapping products.
Increase Productivity
Clever design combined with an intuitive user interface to create user-friendly systems that increase uptime and boost productivity.
-
Ensuring the integrity of results and maintaining regulatory compliance are paramount concerns for any lab today, especially with increasingly complex laboratory processes. Cloud-based device management offers several advantages for laboratory equipment monitoring.
WHITE PAPERS AND CASE STUDIES
-
Getting Started With Product Development Strategies
Simplify and streamline new product development for success. Explore the importance of new product innovation, different process methods, and best practices for optimizing your company’s strengths.
-
Electronic Batch Reporting
Learn how a CDMO automatically created a comprehensive batch report model to drive their reporting and speed root cause identification of quality failures with an Industrial DataOps software solution.
-
What Does Pharma 4.0 Mean To Cell and Gene Therapy Drug Manufacturers?
Explore the benefits of Pharma 4.0 for CGT companies along with the challenges they may face when implementing the convergence of people, systems, and data within a singular network.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times
Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
How Digitized Protocols Are Accelerating Clinical Research
Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.
-
New Duke Research Shows Participants Prefer Enhanced eConsent
It’s apparent to those who have used it that the “e” in eConsent could stand for much more than 'electronic'. Duke’s new research shows why participants prefer an eConsent experience bolstered with videos, media, questions, and more.
-
Clarification Of HEK293 Cells Using Centrifugation
Clarify HEK293 cells in various stages of production from research to manufacturing with a family of products that demonstrate high yield and viability rates while maintaining target NTU readings.
-
Designing More Precise Clinical Trials Using AI-Driven Analytics
Clinical trials face staggering failure rates and inefficiencies. Discover how AI and real-world evidence streamline patient recruitment and trial design to help reshape the future of clinical research.
-
FDA Recommendations For Gene Therapy For PMDs
Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).
-
A New Approach To Characterizing Crystalline Structure
Learn how the accuracy (melting temperature and heat of fusion) and utility of Differential Scanning Calorimetry data is greatly diminished for materials that undergo Apparent Melting and much more.
-
Case Study: Connexin Is Taking The UK's 'Smart Cities' To The Next Level
With Skedulo, Connexin is streamlining processes via automation, increasing connectedness between their office & field teams, and elevating their customer experience.
NEWS
-
SMC Tollways Now With AI-Enabled License Plate-Recognition Cameras, Ready For Barrier-Less Expressways11/29/2024
SMC Infrastructure said it has completed fitting all its active toll gates with artificial intelligence (AI)-enabled automatic license plate recognition (ALPR) cameras, which will pave the way for barrier-less toll plazas across its expressway network.
-
Waste-To-Energy Market Insights: Growth, Trends3/10/2025
Waste-to-energy (WtE) is an innovative process that transforms municipal solid waste (MSW) into usable forms of energy, such as electricity, heat, or fuel.
-
Quark Embeds AI To Convert Unstructured Into Structured Content In Newest Release Of Quark Publishing Platform NextGen4/17/2024
Quark Software, the global provider of content automation, intelligence and design software, today announced the newest release of Quark Publishing Platform (QPP) NextGen, its cloud-based content automation platform that simplifies the complexities associated with the entire enterprise content lifecycle management process, from creation to consumption, in a fully integrated CCMS.
-
Zscaler Unveils AI Innovations To Power The Industry's Most Comprehensive Data Protection Platform6/14/2024
Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, announced multiple innovations to its AI Data Protection Platform that leverage the world’s largest security cloud and the power of AI
-
POET Technologies Announces ZKTel As Customer And Collaborator1/3/2024
POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, telecommunication and artificial intelligence markets, today announced that Shaoxing ZKTel Equipment Co. (“ZKTel”), which supplies optical computer equipment such as modules and transceivers to Tier 1 companies in China’s datacom and mobile networking industries, is one of the lead customers for POET’s 100G optical engines.